Complete PET/CT extinction and subsequent risk of aortic dilation in patients with giant cell arteritis-related large vessel vasculitis treated with tocilizumab. [PDF]
Dumont A +17 more
europepmc +1 more source
Interobserver Variability in Cardiovascular FDG PET/CT Analysis in Large Vessel Vasculitis. [PDF]
Kimeu R +4 more
europepmc +1 more source
Current and Emerging Approaches to Imaging Large Vessel Vasculitis. [PDF]
Tawakol A +11 more
europepmc +1 more source
FDG-PET/CT as a useful tool for disease activity assessment in large vessel vasculitis in childhood. [PDF]
Krickau T +5 more
europepmc +1 more source
Editorial: New insights into the role of imaging in large vessel vasculitis. [PDF]
Molina-Collada J +4 more
europepmc +1 more source
Concurrent Large-vessel Vasculitis and Small-vessel Vasculitis Accompanied by Basal Cell Carcinoma. [PDF]
Nawata T +7 more
europepmc +1 more source
Biologic therapies for the treatment of large vessel vasculitis: A systematic review and meta-analysis. [PDF]
Chen S, Cui X, Chen Y, Guo X.
europepmc +1 more source
Risk factors of serious infections in patients with large-vessel vasculitis after the approval of tocilizumab in 2017: a retrospective nested case-control study using the Japanese health insurance database. [PDF]
Horiuchi S +6 more
europepmc +1 more source
Proteomic Profiling of the Large-Vessel Vasculitis Spectrum Identifying Shared Signatures of Innate Immune Activation and Stromal Remodeling. [PDF]
Maughan RT +15 more
europepmc +1 more source

